Cosponsor
Sign in

S 1186 · in committee · major

Lower Drug Costs for Families Act

What this bill does

  • The bill extends Medicare drug rebate rules to prescription drugs sold through private health insurance plans.
  • Drug manufacturers selling brand-name drugs without generic alternatives are affected by the new rebate requirements.
  • Manufacturers must issue rebates for drugs costing $100+ yearly with price increases above inflation, or face civil penalties.

Generated by claude-haiku-4-5

Community Threads

Started by Cosponsor

  1. 01

    How might extending Medicare's rebate requirements to private insurance plans affect drug prices for non-Medicare patients?

  2. 02

    Which manufacturers and drug types would face the most significant financial impact from the inflation-based rebate penalties?

  3. 03

    What evidence suggests that rebates passed to insurers will translate into lower out-of-pocket costs for individual patients?

Cosponsor writes these to seed civic discussion — they aren't user posts. Sign in to reply.

Sponsor · D-NV

Catherine Cortez Masto

Citizen cosponsors

0

In Congress

12/ 100

Senators cosponsoring

Introduced 2025-03-27

Joining the bill

Legislative timeline

  1. 2025-03-27 · senate · IntroReferral

    Read twice and referred to the Committee on Finance.

  2. 2025-03-27 · IntroReferral

    Introduced in Senate

Congress.gov ↗

Citizen comments

Sign in to comment on this bill.

No comments yet — be the first.